JSPR Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Chartmill - Mentions: DBVT MYSZ EB SGN ...

These stocks have an unusual volume in today's session

5 days ago - By: Chartmill - Mentions: CEP NCT PRPH MDB ...

These stocks are moving in today's pre-market session

5 days ago - By: Jasper Therapeutics, Inc.

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

6 days ago - By: Chartmill - Mentions: IRBT PRPH CLSD MDB ...

What's going on in today's after hours session

6 days ago - By: Jasper Therapeutics, Inc.

Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation

15 days ago - By: Bragar Eagel & Squire - Mentions: DRVN

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Driven Brands and Jasper Therapeutics on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

19 days ago - By: Faruqi & Faruqi, LLP

JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit

20 days ago - By: Bragar Eagel & Squire - Mentions: KBR MOH

Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the Firm

20 days ago - By: The Law Offices of Frank R. Cruz

Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

20 days ago - By: Schall Law

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

21 days ago - By: The Rosen Law Firm PA

JSPR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR

23 days ago - By: THE ROSEN LAW FIRM, P. A.

JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit

23 days ago - By: Faruqi & Faruqi, LLP

JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR

24 days ago - By: Schall Law

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

a month ago - By: Benzinga - Mentions: CRWV CRWD JPM

CoreWeave Bulls Should Brace For 'Wild, Lumpy, Volatile Ride,' JPMorgan Says

a month ago - By: Bragar Eagel & Squire - Mentions: KBR MOH

Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit, and Molina to Contact the Firm About their Rights

a month ago - By: Schall Law

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

a month ago - By: Jasper Therapeutics, Inc.

Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

a month ago - By: THE ROSEN LAW FIRM, P. A.

JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit

a month ago - By: Faruqi & Faruqi LLP

JSPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit

a month ago - By: Faruqi & Faruqi, LLP

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

a month ago - By: The Rosen Law Firm, P.A.

JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights

a month ago - By: Schall Law

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

a month ago - By: Faruqi & Faruqi, LLP

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics

a month ago - By: THE ROSEN LAW FIRM, P. A.

JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit

a month ago - By: The Rosen Law Firm PA

JSPR DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JSPR

a month ago - By: Faruqi & Faruqi LLP

JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

a month ago - By: Jasper Therapeutics, Inc.

Jasper Therapeutics to Present at Upcoming Investor Conferences

a month ago - By: Bragar Eagel & Squire

JASPER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Jasper Stockholders of the November 18th Deadline for Filed Class Action

a month ago - By: Schall Law

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

a month ago - By: Faruqi & Faruqi, LLP

JSPR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In JSPR To Contact Him Directly To Discuss Their Options

JASPER THERAPEUTICS INC (JSPR) Stock News

JSPR Latest News, Press Relases and Analysis